Charles River Laboratories International Inc (NYSE:CRL)
$ 214.2 25.52 (13.53%) Market Cap: 10.95 Bil Enterprise Value: 13.50 Bil PE Ratio: 25.59 PB Ratio: 2.97 GF Score: 87/100

Charles River Laboratories International Inc at Wells Fargo Virtual Healthcare Conference Transcript

Sep 09, 2021 / 02:00PM GMT
Release Date Price: $443 (-0.56%)
Daniel Louis Leonard
Wells Fargo Securities, LLC, Research Division - Senior Analyst

Great. Well, welcome, everybody, to the Charles River Labs fireside chat. With us today, we have David Smith, CFO. If you have questions, please e-mail them to me at [email protected] or use the question tab in your conference portal.

Questions & Answers

Daniel Louis Leonard
Wells Fargo Securities, LLC, Research Division - Senior Analyst

So with that, let's kick things off. Well, welcome, David. And the first question is the typical question. Can you offer us an update on the business environment? How things are trending compared to the conditions you contemplated in your upsized revenue guidance for 2021?

David Ross Smith
Charles River Laboratories International, Inc. - Corporate Executive VP & CFO

Yes, sure. So the latest guidance we gave was 13% to 15% organic sales growth, which is actually up from the 9% to 11% that we started the year with. And even when you back out COVID, we're nicely into double

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot